Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Neurovirol. 2015 Mar 5;21(4):415–421. doi: 10.1007/s13365-015-0330-6

Table 1.

Baseline demographic and clinical characteristics of the women by quartile of HOMA-IR

Lowest Quartile 2nd Quartile 3rd Quartile Highest Quartile p-value
HOMA-IR range <0.72 0.72-1.52 1.521-2.81 >2.81
Sample size 248 252 247 247
Age, mean (SD) 43.4 (9.0) 45.2 (9.5) 45.8 (9.4) 45.9 (9.1) 0.01
Years of Education, mean (SD) 12.5 (3.1) 12.8 (2.7) 12.6 (2.8) 11.9 (3.0) 0.01
WRAT-R, mean (SD) 91.9 (19.0) 93.2 (15.8) 92.5 (17.8) 88.5 (18.7) 0.02
Race, % 0.16
 African-American, non-Hispanic 66% 67% 70% 62%
 White, non-Hispanic 12% 13% 8% 9%
 Hispanic 20% 16% 18% 26%
 Other 2% 4% 4% 3%
HIV status, %HIV-uninfected 22% 24% 26% 28% 0.003
CES-D ≥16, % 28% 23% 28% 35% 0.03
Hepatitis C positive, % 10% 18% 19% 24% 0.001
Metabolic Parameters
 BMI, mean+SD 25.9 (6.1) 28.8 (6.8) 31.2 (7.3) 33.5 (9.4) <0.001
 Hypertension, % 29% 33% 34% 44% 0.005
 Smoking status, % 0.80
  Never 26% 31% 28% 26%
  Former 47% 41% 42% 43%
  Recent 27% 28% 30% 31%
 Fasting Chol. mg/dl, mean (SD) 173.6 (32.8) 178.5(38.3) 180.7(39.9) 179.4 (37.6) 0.17
 MAP, mean (SD) 89.8 (13.4) 91.0 (13.1) 90.9 (12.4) 91.4 (12.8) 0.53
 Waist-hip ratio 0.87+0.07 0.89+0.07 0.91+0.07 0.93+0.07 <0.001
Recent Alcohol use, % 0.01
 Abstainer 46% 52% 55% 61%
 Not heavy 25% 29% 24% 23%
 Heavy 29% 19% 21% 16%
cART >95% compliance 60% 61% 68% 68%
 CD4 count, % 0.60
 >500 47% 47% 54% 52%
 200-500 36% 41% 31% 35%
 <200 16% 12% 15% 13%
Plasma HIV RNA, % 0.03
 Undetectable 47% 50% 56% 61%
 <10,000 35% 40% 29% 25%
 ≥10,000 18% 10% 15% 14%

Note. WRAT-R = Wide Range Achievement Test Scaled Score. “Recent” refers to within 6 months of the most recent WIHS visit. “Former” refers to any previous use, but not in the past 6 months.

CES-D = Center for Epidemiologic Studies Depression Scale; cART = combination antiretroviral therapy; MAP = mean arterial pressure.